
Results
10
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
10 companies
Selvita
Market Cap: zł811.3m
Operates as a contract research organization worldwide.
SLV
zł44.20
7D
8.1%
1Y
-11.1%
Ryvu Therapeutics
Market Cap: zł627.7m
A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.
RVU
zł27.15
7D
7.1%
1Y
-30.1%
BIOTON
Market Cap: zł339.2m
A biotechnology company, develops, manufactures, markets, and sells pharmaceutical ingredient and medicinal products in Poland and internationally.
BIO
zł3.95
7D
5.1%
1Y
25.0%
Poltreg
Market Cap: zł118.9m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł25.50
7D
3.7%
1Y
-37.7%
Read-Gene
Market Cap: zł64.4m
Engages in the detection, prevention, and treatment of various types of cancer.
RDG
zł5.46
7D
-0.7%
1Y
8.3%
Biogened
Market Cap: zł53.1m
Produces and sells cosmetics and toiletries in Poland.
BGD
zł21.60
7D
4.9%
1Y
-6.9%
Genomed Spólka Akcyjna
Market Cap: zł40.4m
Provides DNA sequencing and analysis and diagnostics services for congenital diseases in Poland.
GEN
zł30.60
7D
27.5%
1Y
11.7%
Stem Cells Spin
Market Cap: zł17.5m
Operates as a biotechnology company in Poland.
SCS
zł0.42
7D
2.9%
1Y
96.3%
genXone
Market Cap: zł13.5m
Operates in the biotechnology industry in Poland and internationally.
GX1
zł4.10
7D
-1.2%
1Y
-40.9%
Labocanna
Market Cap: zł4.2m
Engages in the cultivation, production, and distribution of hemp product.
LCN
zł0.20
7D
5.3%
1Y
-41.0%